Trials / Completed
CompletedNCT06030999
The Prevention And Treatment On Obesity And Weight Management By Oral Supplementation Of Probiotics And Prebiotics
Three Arms, Randomized, Double-blind Controlled Trial Of Prevention And Treatment On Obesity And Weight Management By Oral Supplementation Of Probiotics And Prebiotics
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (actual)
- Sponsor
- Shenzhen Precision Health Food Technology Co. Ltd., · Other Government
- Sex
- All
- Age
- 25 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The goal of this interventional study is to test whether consumption of Wonderlab probiotics with prebiotics could improve obesity and overweight in Chinese people who are aged 25-45 and overweight. The main question it aims to answer is: \- whether the weight of participants can be lost after 10 weeks' intervention 150 participants will be randomized into 3 study groups (50 each group) in the two study sites, who will consume assigned product according to instructions for 10 weeks. Three site visits will be made for each participant and all relevant clinical data will be captured and recorded into CTMS(Clinical Trial Management System) for statistical analysis. Researchers will compare the three groups to conclude whether the Wonderlab study product can improve obesity and overweight over placebo product.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Study product A (Wonderlab wonder4shape) | Participants in this arm need to consume one bottle (2g) of this product once a day for 10 weeks |
| DIETARY_SUPPLEMENT | Study product B (Wonderlab wonder4shape) | Participants in this arm need to consume one bottle (2g) of this product once a day for 10 weeks |
| DIETARY_SUPPLEMENT | Study product C (placebo) | Participants in this arm need to consume one bottle (2g) of this product once a day for 10 weeks |
Timeline
- Start date
- 2023-09-18
- Primary completion
- 2023-12-02
- Completion
- 2023-12-15
- First posted
- 2023-09-11
- Last updated
- 2024-02-21
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06030999. Inclusion in this directory is not an endorsement.